Esmolol Titration Protocol for Heart Rate and Blood Pressure Control

Initial Dosing Strategy

The American Heart Association recommends a loading dose of 500-1000 mcg/kg/min over 1 minute followed by an initial infusion of 50 mcg/kg/min for heart rate control, with incremental increases of 50 mcg/kg/min every 5-10 minutes as needed up to a maximum of 200 mcg/kg/min 1, 2
For hypertensive emergencies, the American College of Cardiology recommends a loading dose of 500-1000 mcg/kg over 1 minute, followed by an initial maintenance infusion of 50-150 mcg/kg/min, with titration increases of 50 mcg/kg/min as needed 2

The onset of action of esmolol is 1-2 minutes, and the duration of action is 10-30 minutes, with a steady-state beta-blockade achieved within 5 minutes of infusion 3, 4

The American Heart Association recommends monitoring heart rate continuously, with a target depending on the clinical scenario, and monitoring blood pressure every 5 minutes during initial titration, then every 15 minutes once stable 1, 2
The European Society of Cardiology recommends monitoring ECG for bradycardia, heart block, or other conduction abnormalities, and monitoring for signs of hypoperfusion, such as symptoms of inadequate cardiac output 1, 2

In acute aortic disease, the European Society of Cardiology recommends targeting systolic BP ≤120 mmHg and heart rate ≤60 bpm, and considering combination with vasodilators like nitroprusside or clevidipine 4, 5
In acute coronary syndrome, the European Society of Cardiology recommends using esmolol to reduce myocardial oxygen demand without jeopardizing diastolic filling time, and considering combination with nitroglycerine if tachycardia is present 3, 4

The American College of Cardiology recommends avoiding concurrent beta-blocker therapy, bradycardia, second or third-degree AV block, decompensated heart failure, and asthma or reactive airway disease, as these are contraindications for esmolol use 1, 2, 5, 6
The American Heart Association recommends considering lower initial infusion rates in elderly patients or those with lower baseline blood pressure, and considering lower maintenance doses in Asian patients 6